424 related articles for article (PubMed ID: 24769646)
21. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
[TBL] [Abstract][Full Text] [Related]
22. All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damage.
Xu Z; Shao J; Li L; Peng X; Chen M; Li G; Yan H; Yang B; Luo P; He Q
BMC Cancer; 2016 Jan; 16():2. PubMed ID: 26728137
[TBL] [Abstract][Full Text] [Related]
23. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
[TBL] [Abstract][Full Text] [Related]
24. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.
Chen Y; Li S; Zhou C; Li C; Ru K; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang B; Wang M; Wang J
Blood; 2014 Aug; 124(6):936-45. PubMed ID: 24782508
[TBL] [Abstract][Full Text] [Related]
25. C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.
Tang D; Hu P; Zhu D; Luo Y; Chen M; Zhang G; Wang Y
Aging (Albany NY); 2021 Apr; 13(9):13179-13194. PubMed ID: 33901013
[TBL] [Abstract][Full Text] [Related]
26. The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations.
Huang G; Zhao X; Wang L; Elf S; Xu H; Zhao X; Sashida G; Zhang Y; Liu Y; Lee J; Menendez S; Yang Y; Yan X; Zhang P; Tenen DG; Osato M; Hsieh JJ; Nimer SD
Blood; 2011 Dec; 118(25):6544-52. PubMed ID: 22012064
[TBL] [Abstract][Full Text] [Related]
27. Transcription therapy for acute promyelocytic leukaemia.
Douer D
Expert Opin Investig Drugs; 2000 Feb; 9(2):329-46. PubMed ID: 11060680
[TBL] [Abstract][Full Text] [Related]
28. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
29. p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells.
Gianni M; Peviani M; Bruck N; Rambaldi A; Borleri G; Terao M; Kurosaki M; Paroni G; Rochette-Egly C; Garattini E
Leukemia; 2012 Aug; 26(8):1850-61. PubMed ID: 22354283
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
31. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
[TBL] [Abstract][Full Text] [Related]
32. Altered nuclear cofactor switching in retinoic-resistant variants of the PML-RARα oncoprotein of acute promyelocytic leukemia.
Farris M; Lague A; Manuelyan Z; Statnekov J; Francklyn C
Proteins; 2012 Apr; 80(4):1095-109. PubMed ID: 22228505
[TBL] [Abstract][Full Text] [Related]
33. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
Ding W; Li YP; Nobile LM; Grills G; Carrera I; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
Blood; 1998 Aug; 92(4):1172-83. PubMed ID: 9694705
[TBL] [Abstract][Full Text] [Related]
34. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
Tomita A; Buchholz DR; Obata K; Shi YB
J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
[TBL] [Abstract][Full Text] [Related]
35. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR
Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha.
Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E
Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454
[TBL] [Abstract][Full Text] [Related]
37. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
38. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
[TBL] [Abstract][Full Text] [Related]
39. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
40. Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells.
Côté S; Rosenauer A; Bianchini A; Seiter K; Vandewiele J; Nervi C; Miller WH
Blood; 2002 Oct; 100(7):2586-96. PubMed ID: 12239173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
